Search the Community

  • Fri
  • 12/14/2012
  • 12:10 PM
  • Sherwin-Williams to Webcast 2012 Year-End Financial Results ...

    CLEVELAND, Dec. 14, 2012 (CRWENewswire)-- The Sherwin-Williams Company (NYSE:SHW) will issue a press release announcing its financial results for the fourth quarter and year ended December 31, 2012 prior to the opening of the market on Thursday, January 31, 2013. At that time, a copy of the press release and information regarding Sherwin-Williams' financial condition, operating segment results and other information will be available by clicking on this link http://investors.sherwin-williams.com/press/index.jsp, then clicking on the reference to the January 31st release. The Company will conduct a conference call to discuss its financial results for the fourth quarter and full year 2012, and its outlook for the first quarter and full year 2013, at 11:00 a.m. ET on Thursday, January 31, 2013. Participating in the call will be Sherwin-Williams' Chairman and Chief Executive Officer, Christopher M. Connor, along with other senior executives. The conference call will be webcast simultaneousl...

     
  • 12/12/2012
  • 8:54 AM
  • 3M Affirms 2012 EPS Expectations and Addresses 2013 Outlook

    ST. PAUL, Minn.--(CRWENewswire)--On a conference call with analysts and investors, 3M (NYSE:MMM) today will affirm its 2012 earnings-per-share target of $6.27 to $6.35 and provide a roadmap for the company’s 2013 performance expectations. 3M anticipates 2013 earnings to be in the range of $6.70 to $6.95 per share with organic local-currency sales growth of 2 to 5 percent for the year. The company expects that free cash flow conversion will be in the range of 90 to 100 percent. "I look forward to another strong year for 3M,” said Inge G. Thulin, 3M chairman, president and chief executive officer. "Our unique combination of technology, manufacturing prowess and global capability – along with inherent operational excellence – will enable us to once again grow sales and profits." Today’s conference call will begin at 9:30 a.m. ET (8:30 a.m. CT). Investors can access the conference via the following: Live webcast at http://investor.3M.com Live telephone: Call 800-762-2596 within t...

     
  • 12/11/2012
  • 2:39 PM
  • Pernix Therapeutics to Acquire Somaxon Pharmaceuticals (SOMX...

    SOMX, Somaxon Pharmaceuticals, Inc. Pernix Therapeutics Holdings, Inc. and SOMX reported that they have entered into a definitive merger agreement for Pernix to acquire SOMX in a stock-for-stock transaction with a total equity value of $25 million. Under the terms of the agreement, which has been unanimously approved by the boards of directors of both companies, SOMX stockholders will receive aggregate consideration equal to $25 million in Pernix common stock. SOMX is a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and/or high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. More about SOMX at www.somaxon.com Read Full Disclaimer at http://pennyomega.com/disclaimer

     
  • 12/10/2012
  • 8:35 AM
  • Trius Therapeutics Completes Enrollment in Second Phase 3 Tr...

    SAN DIEGO, Dec. 10, 2012 (CRWENewswire) -- Trius Therapeutics, Inc. (Nasdaq:TSRX), a biopharmaceutical company focused on the discovery and development of innovative antibiotics for life-threatening infections, announced today that it has reached its enrollment objective of 658 patients in the last of its two Phase 3 clinical trials of tedizolid phosphate (TR-701) for the treatment of acute bacterial skin and skin structure infections (ABSSSI). The pivotal Phase 3 trial, designated ESTABLISH 2, examines the efficacy and safety of a six-day course of tedizolid administered once a day versus a 10-day course of linezolid (Zyvox(R)) administered twice a day in patients recruited across sites in North and South America, Europe, Australia, New Zealand and South Africa. For both tedizolid phosphate and linezolid, drug was initially administered as an intravenous (IV) infusion with the option to switch to oral therapy after the initial day of therapy. "As with our ESTABLISH 1 study, ESTABLISH ...

     
  • 12/7/2012
  • 10:37 AM
  • PNM Resources Announces 2013 Ongoing Earnings Guidance Range

    Company to provide details during webcast today at 10 a.m. Eastern; 2012 guidance affirmed ALBUQUERQUE, N.M.--(CRWENewswire)--PNM Resources (NYSE:PNM) management today announced the company’s 2013 consolidated ongoing earnings guidance range of $1.32 to $1.42 per diluted share. Management will host a meeting with analysts and investors to discuss details of the guidance range and provide company updates. The meeting will be webcast live today from 10 a.m. until 1 p.m. Eastern. The presentation and live webcast will be available and archived prior to the start of the meeting on PNM Resources’ website at http://www.pnmresources.com/investors/events.cfm. Listeners are encouraged to visit the website at least 30 minutes before the event to register, download and install any necessary audio software. Also today, management affirmed the company’s 2012 consolidated ongoing earnings guidance range of $1.26 to $1.32 per diluted share. Background: PNM Resources (PNM) is an energy holding company...

     
  • 12/5/2012
  • 11:57 AM
  • Freeport-McMoRan Copper & Gold Inc. to Acquire Plains Explor...

    Adds High Quality U.S. Oil & Gas Resources to Global Mining Portfolio Combined Company Will Have Portfolio of Geographically Diverse, Long-lived Mining and Oil & Gas Assets with Strong Current Cash Flows and Financially Attractive Growth Profile Pro forma Company Enterprise Value of $60 Billion Accretive to FCX Operating Cash Flows PHOENIX & HOUSTON & NEW ORLEANS--(CRWENewswire)--Freeport-McMoRan Copper & Gold Inc. (NYSE:FCX), Plains Exploration & Production Company (NYSE:PXP) and McMoRan Exploration Co. (NYSE:MMR) announced today that they have signed definitive merger agreements under which FCX will acquire PXP for approximately $6.9 billion in cash and stock and FCX will acquire MMR for approximately $3.4 billion in cash, or $2.1 billion net of 36 percent of the MMR interests currently owned by FCX and PXP. Upon closing, MMR shareholders will also receive a distribution of units in a royalty trust which will hold a 5 percent overriding royalty interest on future produ...

     
  • 12/4/2012
  • 11:35 AM
  • China XD Plastics Announces Outcome of 2012 Annual Sharehold...

    HARBIN, China, Dec. 4, 2012 (CRWENewswire) -- China XD Plastics Company Limited (NASDAQ:CXDC, "China XD Plastics" or the "Company"), one of China's leading company engaged in the development, manufacture and sale of modified plastics primarily for automotive applications, today announced that the Company's shareholders voted upon all the proposals as recommended by the board at the 2012 annual shareholders meeting held in HARBIN, China on December 3, 2012. The following two proposals were approved by the Company's shareholders at the 2012 annual shareholders meeting: 1. Elect a total of eight (8) directors to the Board of Directors of the Company, including two (2) directors elected solely by the holders of the Company's Series D Preferred Stock (the "Series D Directors"), to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified. 2. Ratify the appointment of KPMG as the Company's independent auditor for the fiscal year ending Dece...

     
  • 11/30/2012
  • 1:42 PM
  • Superior Venture Corp. Raises Film Development Financing to ...

    International Film Company Has Developed a Funding Mechanism Through Its Wholly Owned Subsidiary, Ilustrato Pictures to Launch Chinese Film Development Co-Productions With a Unique Repatriation and Box Office Model LONDON, England, Nov. 30, 2012 (CRWENewswire) Superior Venture Corp. ("Superior" or "the Company") (OTCQB:SVEN) has developed a funding mechanism through its wholly owned subsidiary, Ilustrato Pictures ("Ilustrato"), to launch Chinese film development co-productions with a unique repatriation and box office model. "Through our subsidiary, Ilustrato Pictures Limited, Superior Venture Corp. has created a new and ingenious model to enter the rapid growth Chinese movie market", states Brian Hammond, President and CEO of Superior Venture Corp. and co-founder of Ilustrato. "We have found that there is a real need in China for co-creating films from the ground up to satisfy both the Chinese domestic and international markets. After developing relationships and discussions with Chin...

     
  • 11/28/2012
  • 12:33 PM
  • EMCOR Group, Inc. Subsidiary Awarded Restoration of Rocket T...

    NORWALK, Conn.--(CRWENewswire)--EMCOR Group, Inc. (NYSE:EME), a Fortune 500® leader in mechanical and electrical construction, energy infrastructure, and facilities services for a diverse range of businesses announced that its subsidiary Harry Pepper & Associates has been awarded by NASA a Task Order under a previously awarded Indefinite Delivery Indefinite Quantity Contract. The Task Order is for restoration of the B2 Rocket Test Stand at the John C. Stennis Space Center in Hancock County, Mississippi. Harry Pepper & Associates (HPA) will be responsible for all repairs and alterations necessary to restore the original functionality of the B-2 Rocket Engine Test Stand. Scope of work includes demolishing one of the major levels/decks of the Test Stand, reconstructing it with stainless steel structural framing and deck plate, and restoring its various areas of fixed deck by replacing the carbon steel, galvanized grating, and structural steel. Additionally, scope of work includes demolish...

     
  • 11/7/2012
  • 11:26 AM
  • U.S. Cellular (USM) to Sell Select Midwest Markets to Sprint...

    USM, United States Cellular Corp. USM reported strategic actions designed to increase focus on markets where it has strong positions and streamline operations to increase overall efficiency and effectiveness. USM has reached a definitive agreement to sell its Chicago, St. Louis, central Illinois and three other Midwest markets to subsidiaries of Sprint Nextel Corporation for $480 million. The sale includes PCS spectrum and approximately 585,000 customers, or about 10 percent of USM's total customer base. USM also said that it will transition its Bolingbrook Customer Care Center operations to an existing vendor partner, effective Jan. 1, 2013. USM provides a comprehensive range of wireless products and services, excellent customer support, and a high-quality network to approximately 5.8 million customers in 26 states. More about USM at www.uscellular.com Read Full Disclaimer at http://stockbling.com/disclaimer

    1 2 3 4 5 6 7 8 9 10 Next >>